ALVOTECH SA (ALVO) Fundamental Analysis & Valuation

NASDAQ:ALVO • LU2458332611

Current stock price

3.47 USD
-0.07 (-1.98%)
At close:
3.47 USD
0 (0%)
After Hours:

This ALVO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ALVO Profitability Analysis

1.1 Basic Checks

  • ALVO had positive earnings in the past year.
  • ALVO had a negative operating cash flow in the past year.
  • In the past 5 years ALVO always reported negative net income.
  • In the past 5 years ALVO always reported negative operating cash flow.
ALVO Yearly Net Income VS EBIT VS OCF VS FCFALVO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -200M -400M

1.2 Ratios

  • ALVO has a Return On Assets of 4.93%. This is amongst the best in the industry. ALVO outperforms 91.33% of its industry peers.
  • ALVO's Return On Invested Capital of 3.10% is amongst the best of the industry. ALVO outperforms 89.60% of its industry peers.
Industry RankSector Rank
ROA 4.93%
ROE N/A
ROIC 3.1%
ROA(3y)-46.35%
ROA(5y)-38.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALVO Yearly ROA, ROE, ROICALVO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

  • ALVO has a Profit Margin of 12.12%. This is amongst the best in the industry. ALVO outperforms 91.71% of its industry peers.
  • The Operating Margin of ALVO (7.57%) is better than 89.98% of its industry peers.
  • The Gross Margin of ALVO (55.59%) is better than 77.07% of its industry peers.
Industry RankSector Rank
OM 7.57%
PM (TTM) 12.12%
GM 55.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALVO Yearly Profit, Operating, Gross MarginsALVO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. ALVO Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALVO is destroying value.
  • ALVO has more shares outstanding than it did 1 year ago.
  • ALVO has a better debt/assets ratio than last year.
ALVO Yearly Shares OutstandingALVO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 100M 200M 300M
ALVO Yearly Total Debt VS Total AssetsALVO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • Based on the Altman-Z score of -1.23, we must say that ALVO is in the distress zone and has some risk of bankruptcy.
  • ALVO has a Altman-Z score (-1.23) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.23
ROIC/WACC0.48
WACC6.41%
ALVO Yearly LT Debt VS Equity VS FCFALVO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

  • A Current Ratio of 1.42 indicates that ALVO should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.42, ALVO is doing worse than 82.27% of the companies in the same industry.
  • ALVO has a Quick Ratio of 1.42. This is a bad value and indicates that ALVO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ALVO's Quick ratio of 0.74 is on the low side compared to the rest of the industry. ALVO is outperformed by 88.44% of its industry peers.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 0.74
ALVO Yearly Current Assets VS Current LiabilitesALVO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. ALVO Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 122.99% over the past year.
  • ALVO shows a strong growth in Revenue. In the last year, the Revenue has grown by 426.84%.
  • The Revenue has been growing by 42.86% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)122.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)426.84%
Revenue growth 3Y131.44%
Revenue growth 5Y42.86%
Sales Q2Q%0%

3.2 Future

  • Based on estimates for the next years, ALVO will show a very strong growth in Earnings Per Share. The EPS will grow by 41.54% on average per year.
  • ALVO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.58% yearly.
EPS Next Y115.24%
EPS Next 2Y57.41%
EPS Next 3Y41.54%
EPS Next 5YN/A
Revenue Next Year27.6%
Revenue Next 2Y32.32%
Revenue Next 3Y30.11%
Revenue Next 5Y26.58%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALVO Yearly Revenue VS EstimatesALVO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2029 2030 500M 1B 1.5B
ALVO Yearly EPS VS EstimatesALVO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1

More info and screens

Find the best growth stocksShow best growing peers

6

4. ALVO Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 17.35, ALVO is valued on the expensive side.
  • Based on the Price/Earnings ratio, ALVO is valued cheaper than 94.03% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.70. ALVO is valued slightly cheaper when compared to this.
  • ALVO is valuated reasonably with a Price/Forward Earnings ratio of 8.35.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ALVO indicates a rather cheap valuation: ALVO is cheaper than 97.88% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.84. ALVO is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 17.35
Fwd PE 8.35
ALVO Price Earnings VS Forward Price EarningsALVO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALVO is valued cheaper than 92.49% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 29.65
ALVO Per share dataALVO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

  • ALVO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ALVO's earnings are expected to grow with 41.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.15
PEG (5Y)N/A
EPS Next 2Y57.41%
EPS Next 3Y41.54%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALVO Dividend Analysis

5.1 Amount

  • ALVO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALVO Fundamentals: All Metrics, Ratios and Statistics

ALVOTECH SA

NASDAQ:ALVO (3/13/2026, 8:09:37 PM)

After market: 3.47 0 (0%)

3.47

-0.07 (-1.98%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-12
Earnings (Next)03-18
Inst Owners5.39%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap1.08B
Revenue(TTM)491.98M
Net Income(TTM)69.50M
Analysts78.33
Price Target8.93 (157.35%)
Short Float %2.12%
Short Ratio5.08
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)206.21%
Min EPS beat(2)-145.1%
Max EPS beat(2)557.52%
EPS beat(4)3
Avg EPS beat(4)215.83%
Min EPS beat(4)-145.1%
Max EPS beat(4)557.52%
EPS beat(8)5
Avg EPS beat(8)737.22%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)18.13%
Min Revenue beat(2)-4.76%
Max Revenue beat(2)41.02%
Revenue beat(4)3
Avg Revenue beat(4)25.91%
Min Revenue beat(4)-4.76%
Max Revenue beat(4)41.02%
Revenue beat(8)4
Avg Revenue beat(8)9.39%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)65.38%
EPS NY rev (1m)-4.88%
EPS NY rev (3m)-45.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.51%
Revenue NY rev (3m)-0.61%
Valuation
Industry RankSector Rank
PE 17.35
Fwd PE 8.35
P/S 1.89
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 29.65
EPS(TTM)0.2
EY5.76%
EPS(NY)0.42
Fwd EY11.98%
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS1.84
BVpS-0.57
TBVpS-0.81
PEG (NY)0.15
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 4.93%
ROE N/A
ROCE 3.93%
ROIC 3.1%
ROICexc 3.23%
ROICexgc 3.47%
OM 7.57%
PM (TTM) 12.12%
GM 55.59%
FCFM N/A
ROA(3y)-46.35%
ROA(5y)-38.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 15.52
Cap/Depr 313.02%
Cap/Sales 19.43%
Interest Coverage 1.69
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 0.74
Altman-Z -1.23
F-Score4
WACC6.41%
ROIC/WACC0.48
Cap/Depr(3y)204.72%
Cap/Depr(5y)182.09%
Cap/Sales(3y)39.66%
Cap/Sales(5y)47.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)122.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y115.24%
EPS Next 2Y57.41%
EPS Next 3Y41.54%
EPS Next 5YN/A
Revenue 1Y (TTM)426.84%
Revenue growth 3Y131.44%
Revenue growth 5Y42.86%
Sales Q2Q%0%
Revenue Next Year27.6%
Revenue Next 2Y32.32%
Revenue Next 3Y30.11%
Revenue Next 5Y26.58%
EBIT growth 1Y306.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year51.53%
EBIT Next 3Y62.37%
EBIT Next 5Y44.7%
FCF growth 1Y61.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y91.44%
OCF growth 3YN/A
OCF growth 5YN/A

ALVOTECH SA / ALVO Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ALVOTECH SA (ALVO) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALVO.


What is the valuation status of ALVOTECH SA (ALVO) stock?

ChartMill assigns a valuation rating of 6 / 10 to ALVOTECH SA (ALVO). This can be considered as Fairly Valued.


Can you provide the profitability details for ALVOTECH SA?

ALVOTECH SA (ALVO) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for ALVO stock?

The Earnings per Share (EPS) of ALVOTECH SA (ALVO) is expected to grow by 115.24% in the next year.